A Study in Healthy Toddlers to Look at the Safety and Immune Response of a Candidate Against Pneumococcal Bacteria
[A Phase 2, Randomized, Open-Label Trial to Describe the Safety and Immunogenicity of a Monovalent Pneumococcal Conjugate
Candidate Administered as a 2-Dose Series in Healthy Toddlers 11 Through 15 Months of Age Who Previously Received the PCV10
Primary Series]
Category & Conditions: Respiratory Disease
Medicine: PF-07831695
ClinicalTrials.gov Identifier (NCT): NCT06116591
Protocol ID: C4801002
Open Plain Language Summary Result:
Click here